---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-24-000032"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2024-07-26T23:59:59+00:00"
generated_at: "2026-05-31T15:56:55.010177+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# iBio amends CEO Martin Brenner's agreement; base salary $522K, bonus target raised to 50% for FY2025

## Summary
- Base salary set at $522,365; FY2025 bonus target increased to 50% of base salary, FY2024 remains 40%.
- Severance without cause or for good reason includes 12 months salary, pro-rata bonus, and COBRA coverage.
- Upon Sale Event termination: 18 months salary, target bonus, and accelerated vesting of time-vested equity.
- Employment is at-will; includes standard termination benefits and non-solicitation/invention assignment clauses.

## SEC filing metadata
- accession: 0001420720-24-000032
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2024-07-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000032/0001420720-24-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072024000032/ibio-20240723x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-24-000032
- JSON: https://secwatch.observer/filing/0001420720-24-000032.json
- Plain text: https://secwatch.observer/filing/0001420720-24-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.